Medicines for Malaria Venture

Activities: Research & Development

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  3. ISPE announces 2024 Facility of the Year Awards category winners The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
  4. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
  5. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Research & Development

Novartis and MMV move to Phase III study to treat uncomplicated malaria

As the world faces emerging resistance to current malaria treatments, new medicines are needed to continue the fight toward elimination
Research & Development

Novartis expands partnership with Medicines for Malaria Venture

To develop next-generation antimalarial treatment in collaboration with the Bill & Melinda Gates Foundation
Research & Development

World Malaria Day looks forward to single tablet treatment

Scientists investigating a new substance that could potentially be used as a single dose therapy in the future
Research & Development

Merck Serono links up with MMV to develop antimalarial

Allows Merck Serono to continue to focus on developing therapies for neglected tropical diseases
Research & Development

Evotec agrees compound management collaboration with Medicines For Malaria Venture

Evotec will use its compound management services to support MMV\'s efforts to distribute research tools to the global malaria research community
Research & Development

Sanofi-aventis and MMV to develop malaria treatments

Sign joint three-year research project agreement
Research & Development

MMV and Anacor to identify new malaria medicines

Anacor’s boron chemistry will be used to develop new therapeutics
Subscribe now